Is TGT a buy, hold, or sell?
TGT carries a valuation grade of Avoid. At a trailing P/E of 17.3, the stock trades at a 28% discount to the Consumer Defensive sector median of 24.0x. Our discounted cash flow model produces an intrinsic range of $95–$160 — implying a -2% margin of safety at the current price of $130.74. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. Analyst estimate revisions are trending upward.
What are TGT's key risk factors?
With a beta of 0.99, TGT exhibits a market-neutral risk profile relative to the broad market. The 95th-percentile CVaR of -14.3% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.4% of total portfolio loss in the worst 5% of months. Net margins of 3.2% fall below the Consumer Defensive sector average of 12%, suggesting margin pressure. Return on equity of 22.0% suggests solid capital efficiency. Leverage is moderate with debt-to-equity at 118%.
Insiders have been net sellers to the tune of $33.3M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 3.5% of float, suggesting limited bearish conviction.
How does TGT fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — TGT carries a beta of 0.99, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all avoidings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, TGT shows the strongest co-movement with AMZN (0.07), WMT (0.05), COST (0.04). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all avoidings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The TGT analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning TGT’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
